ResearcherUniversity Health NetworkActive in the last 2 years
Niklas Krebs
Matched on ORCID iD 0000-0003-1729-7616; OpenAlex author ID A5019830952. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 38
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 5
- Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41467-026-69013-y↗
- Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. Co-author DOI 10.1038/s41467-024-55330-7↗
- Transcription factor switching drives subtype-specific pancreatic cancer. Co-author DOI 10.1038/s41588-025-02389-7↗
- Hourglass, a rapid analysis framework for heterogeneous bioimaging data, identifies sex disparity in IL-6/STAT3-associated immune phenotypes in pancreatic canc… Co-author DOI 10.1002/path.6199↗
- Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer. Co-author DOI 10.1172/jci.insight.154475↗
Closest collaborators
The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Barbara T. Grünwald · 4 shared papers, 2023–2026 · strength 0.71
- Paper Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expressi… DOI 10.1038/s41467-026-69013-y↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Transcription factor switching drives subtype-specific pancreatic cancer. DOI 10.1038/s41588-025-02389-7↗
- Phyllis F. Cheung · 2 shared papers, 2025–2026 · strength 0.37
- Jens Thomas Siveke · 2 shared papers, 2025–2026 · strength 0.37
- Rama Khokha · 2 shared papers, 2023–2025 · strength 0.34
- Kazeera Aliar · 2 shared papers, 2023–2025 · strength 0.34
- Elisa Espinet Espinet · 2 shared papers, 2022–2025 · strength 0.30
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancre… DOI 10.1172/jci.insight.154475↗
- Shiv K. Singh · 2 shared papers, 2022–2025 · strength 0.30
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancre… DOI 10.1172/jci.insight.154475↗
- Uday Kishore · 2 shared papers, 2022–2025 · strength 0.30
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancre… DOI 10.1172/jci.insight.154475↗
- Andreas Trumpp · 2 shared papers, 2022–2025 · strength 0.30
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancre… DOI 10.1172/jci.insight.154475↗
- Lukas Klein · 2 shared papers, 2022–2025 · strength 0.30
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancre… DOI 10.1172/jci.insight.154475↗
- Mengyu Tu · 2 shared papers, 2022–2025 · strength 0.30
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancre… DOI 10.1172/jci.insight.154475↗
- Elisabeth Heßmann · 2 shared papers, 2022–2025 · strength 0.30
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancre… DOI 10.1172/jci.insight.154475↗
- Volker Ellenrieder · 2 shared papers, 2022–2025 · strength 0.30
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancre… DOI 10.1172/jci.insight.154475↗
- Sven‐Thorsten Liffers · 1 shared paper, 2026 · strength 0.20
- Diana Behrens · 1 shared paper, 2026 · strength 0.20
- Juanfei Peng · 1 shared paper, 2026 · strength 0.20
- Marija Trajkovic‐Arsic · 1 shared paper, 2026 · strength 0.20
- Markus Vogt · 1 shared paper, 2026 · strength 0.20
- Elmar Wolf · 1 shared paper, 2026 · strength 0.20
- Laura Godfrey · 1 shared paper, 2026 · strength 0.20
- Rita Teresa Lawlor · 1 shared paper, 2026 · strength 0.20
- Rickmer Braren · 1 shared paper, 2026 · strength 0.20
- Aldo Scarpa Scarpa · 1 shared paper, 2026 · strength 0.20
- Argyris Papantonis · 1 shared paper, 2025 · strength 0.18
- Muhammad Umair Latif · 1 shared paper, 2025 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.